All News

2019

June

Media Release / Jun 12, 2019

Cosentyx® provides long-lasting inhibition of radiographic progression in psoriatic arthritis, new Novartis data show

Read More
Media Release / Jun 12, 2019

Novartis Cosentyx® first to show efficacy in all key manifestations of psoriatic arthritis

Read More
Media Release / Jun 07, 2019

Novartis announces new leader of Pharmaceuticals Business Unit

Read More
Media Release / Jun 06, 2019

Advanced Accelerator Applications Receives Positive CHMP Opinion for LysaKare®

Read More
Media Release / Jun 06, 2019

Novartis presents first-of-its-kind histology data with iscalimab (CFZ533) suggesting the extended survival of transplanted organs may be possible

Read More
Scientists in the lab
Story / Jun 04, 2019

Toward improving the health and longevity of transplanted organs

Novartis researchers are working to extend the life of organ transplants

Read More
Media Release / Jun 04, 2019

Long-term survival benefit shown for metastatic melanoma patients treated with Novartis Tafinlar® + Mekinist®

Read More
Media Release / Jun 03, 2019

Novartis Shows Growing Strength in Lung Cancer Innovation with New Capmatinib Investigational Data and Novel Canakinumab Clinical Trials

Read More
Media Release / Jun 03, 2019

Xolair® (omalizumab) significantly reduced nasal polyps and congestion symptoms in adults with chronic rhinosinusitis with nasal polyps in two phase III studies

Read More
Media Release / Jun 01, 2019

Novartis Kisqali significantly extends life in women with HR+/HER2- advanced breast cancer in MONALEESA-7 trial

Read More

Pages

Related Links

Novartis Annual Reporting Suite

Read and download the Annual Review, the Annual Report and Form 20-F, and the Novartis in Society report.

Learn More